Reliv International (RELV) Stock Research, Analysis & News

Quick Analysis on Reliv International (RELV) Stock as of October 20, 2017

Previous Closing Price $5.82 is below its 50 day moving average $6.84
Previous Closing Price $5.82 is below its 200 day moving average $7.59
The Stock pays no dividend
The closing price $5.82 is more than 260.82% away from its one year target price of $21.00
Good Price to Sale Ratio 0.24
Good Price to Book Ratio of 0.71
Average trading volume is relatively low at 5,475
It is a very small cap stock with market cap of $10.74M
(See more information about Reliv International (RELV) Stock below)

Reliv International (RELV) Stock Profile Summary

Reliv International, Inc. engages in the development, manufacture, and marketing of nutritional supplements. Its basic nutrition supplements include Reliv Classic and Reliv NOW, which offer a balanced blend of vitamins, minerals, proteins, and herbs; NOW for Kids, which provide a balanced nutritional supplement for a childs diet; and Reliv Delight, a powdered nutritional supplement sold as a milk replacement. The companys specific wellness supplements comprise ReversAge, a youth-promoting nutritional supplement to slow down the effects of the aging process; SoySentials for use by women; CardioSentials, which promotes heart health; Arthaffect that supports healthy joint function; FibRestore, which contains fiber, vitamins, minerals, and herbs; and GlucAffect that assists in healthy blood sugar management and supports weight loss. Reliv Internationals weight management supplements include Reliv Ultrim-Plus, a meal replacement; Cellebrate to suppress appetite, curb the storage of body fat, and facilitate the bodys fat burning process; and Slimplicity meal replacement and accelerator capsules. The companys sports nutrition supplements comprise Innergize!, which contains vitamins and minerals for performance enhancement; and ProVantage to increase muscle recovery, muscle mass, and function, as well as to reduce fatigue and burn excess body fat for extra energy. It also offers Relivables product line, which comprises skin care products, marketed as the r skin care collection to create healthier, youthful looking skin. Reliv International, Inc. markets its products through a network of independent distributors in the United States, Australia, Austria, Brunei, Canada, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, the United Kingdom, and Indonesia. The company was founded in 1984 and is headquartered in Chesterfield, Missouri.

Reliv International (RELV) Stock Key Statistics Research and Analysis as of October 20, 2017

Stock ExchangeNCM
Market Capitalization$10.74M
Trade Volume (Average Trading Volume)3,482 (5,475)
Current Year EPS Estimate$0.20
Previous Closing Price$5.82
50 Day Price Moving Average$6.84
200 Day Price Moving Average$7.59
Dividend Yield0.00%
1 yr Target Price$21.00
Ex-Dividend Date11/13/2013
PEG Ratio0.00
Short Ratio0.44

Reliv International (RELV) Stock Competitor Research and Analysis

Herbalife Ltd. (HLF)Mannatech Inc. (MTEX)
Natures Sunshine Products Inc. (NATR)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Pfizer Inc. (PFE)Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)Sanofi-Aventis (SNY)
Novartis AG (NVS)AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)Bristol-Myers Squibb Company (BMY)

Latest Market News on Reliv International (RELV)

Click here to find the latest news on Reliv International (RELV)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Herbalife Ltd. (HLF)
Mannatech Inc. (MTEX)
Natures Sunshine Products Inc. (NATR)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)